This study is not yet open for participant recruitment. Verified by University of Pittsburgh, August 2010 Official Title Randomized Trial of Alternative HPV Vaccination Schedules in Males in a University Setting Purpose The investigators propose a randomized, open label trial of the immunogenicity of HPV vaccine among males 18-24 years old, comparing an on-time administration […]
Immune Response to the Human Papillomavirus Vaccine in Young Women With Inflammatory Bowel Disease
This study is currently recruiting participants. Verified by Mayo Clinic, July 2010 Official Title: Comparison of Immune Response to the Human Papillomavirus Vaccine in Young Women With and Without Inflammatory Bowel Disease Purpose The Gardasil vaccine, a vaccine targeted towards the human papillomavirus (HPV), has been shown to prevent the transmission of several strains of […]
GARDASIL Reexamination Study
This study is currently recruiting participants. Verified by Merck, February 2010 Official Title Re-examination Study for General Vaccine Use to Assess the Safety Profile of GARDASIL in Usual Practice Purpose This survey is conducted for preparing application materials for re-examination under the Pharmaceutical Affairs Laws and its Enforcement Regulation, its aim is to reconfirm the […]
A Study of V503 in Females 12-26 Years of Age Who Have Previously Received GARDASIL™
V503 is a multi-valent HPV vaccine still under development by Merck & Co.
A Study to Evaluate the Safety, Immune Response, and Efficacy of Gardasil (V501) in Women
This study is ongoing, but not recruiting participants. Official Title Safety, Immunogenicity, and Efficacy of Gardasil (V501 (Human Papilloma Virus [Types 6, 11, 16, 18] Recombinant Vaccine) in Mid-Adult Women – The FUTURE III (Females United to Unilaterally Reduce Endo/Ectocervical Cancer) Study Detailed Description: The original base protocol was extended. Subjects in the placebo arm […]